In patients with lung cancer, ALK gene mutations (EML4-ALK) caused by chromosomal inversion promoted the occurrence and progression of lung cancer.[35,36] EGFR TKI drugs and ALK inhibitors can be used to treat patients with advanced lung cancer with EGFR gene mutations and ALK fusion mutations. The gene discussed is EGFR; the disease is lung carcinoma.